Mark Boyar’s Three Undervalued Companies


Mark Boyar does excellent value investing research that he publishes (his firm also manages a mutual fund, Boyar Value (BOYAX) — it’s an expensive fund so I wouldn’t necessarily want to invest there, but his research is great), and he shared a bunch of lessons with us at the Congress today — along with some specific ideas.

Some of the best broad suggestions? Look for excellent brands that are masked by a corporate holder, that’s the kind of undervalued asset that won’t show up in the same cash flow screens that every investor uses — these days, with everyone having the same full data access, you have to search for things that the computers con’t find.

And think like a private equity buyer — companies like Tiffany’s and Saks during down retail cycles were often valued at less than the extraordinarily understated value of their Manhattan real estate.

Analysts ignore off-balance-sheet items during up cycles, but they become very meaningful in down cycles — the home builders, for example, were absurdly overvalued and built on top of cycle valuations in 2006-2007. Boyar said to short housing in 2007, and buy it in 2011 — that’s some excellent timing and went against all the sell side analysts. So that’s another reminder of the importance of being independent.

His ideas today?

Weight Watchers (WTW)

“If obesity was a stock, you’d want to own it and leverage it as much as you could.”

The weight management industry has an estimated $62 billion in revenues, and obesity is increasing worldwide and will reach three billion people in the coming years. 79 million Americans are pre-diabetic, more than a 50% chance of having diabetes in the next five to ten years — that should be a huge driver for weight management companies, 10% weight loss reduces risk of diabetes dramatically … and Weight Watchers has a proven program that’s holistic and effective, with excellent studies backing up the efficacy over the past 20 years.

They have a million members attending 40,000 meetings a week — patients who go to WTW under doctor’s advice lost twice as much weight as people who just try to lose weight under the doctor’s guidance.

They did an ill-timed debt-financed stock buyback at $82 a share, and you can buy it now in the $40s (that was pushed by their large shareholder private equity ...

Sign Up for a Premium Membership

To view the rest of this article (and to have full access to the rest of our articles), sign up.
Already a member, log in.

Become a member

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
Would love your thoughts, please comment.x